MANUFACTURED BY Daewoong Pharmaceutical.
NABOTA available in 15 countries of Latin Amercia, including Mexico, Colombia, Venezuela, and Brazil, the largest market in Latin America.
NABOTA is the high-purity botulinum toxin product developed independently by Daewoong Pharmaceutical and minimized the side effect that may be caused by the diffusion into other tissues from the site of injection. Daewoong Pharmaceutical entered into an export contract worth about KRW 300 billion with the U.S.-based Evolus in September. On November 29, Daewoong Pharmaceutical obtained the approval of the Ministry of Food and Drug Safety for NABOTA slated for release in domestic market from March next year.
1 BOX = $220
3 BOX = $600
5 BOX = $900